Basic information Safety Supplier Related

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT)

Basic information Safety Supplier Related

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT) Basic information

Product Name:
VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT)
Synonyms:
  • H-PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
  • PHE-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2
  • VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT)
  • VIP(6-28)(human, rat, porcine, bovine),FTDNYTRLRKQMAVKKYLNSILN?, >98%
  • VIP(6-28)(HUMAN, RAT, PORCINE, BOVINE)?, >98%
  • VIP (6-28) (HUMAN, RAT, PORCINE, BOVINE)
  • VASOACTIVE INTESTINAL PEPTIDE (6-28) (HUMAN, BOVINE, PORCINE, RAT)
  • VASOACTIVE INTESTINAL PEPTIDE (6-28), HUMAN, PORCINE, RAT
CAS:
69698-54-0
MF:
C126H207N37O34S
MW:
2816.28
Product Categories:
  • VIP and PACAP receptor
  • Peptide Receptors
Mol File:
69698-54-0.mol
More
Less

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT) Chemical Properties

storage temp. 
−20°C
form 
Powder
Water Solubility 
Soluble to 1 mg/ml in water
Sequence
H-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2
More
Less

Safety Information

WGK Germany 
3

MSDS

More
Less

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT) Usage And Synthesis

Biological Activity

VIP(6-28)(human, rat, porcine, bovine) is a potent exogenous vasoactive intestinal peptide (VIP) antagonist.

in vitro

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT) is an effective VIP antagonist in the superior cervical ganglion (SCG) , and results obtained using this analog indicate that endogenous VIP can participate in a positive feedback loop in injured sympathetic neurons in which it enhances its own expression. VIP(6-28), when added to short-term cultures of adult SCG at a concentration of 10, 30, or 100 μM, reduces the increase in cAMP levels produced by stimulation with 10 μM VIP by 52, 64, or 81%, respectively. At any of these concentrations tested, VIP(6-28) by itself does not alter cAMP levels. In contrast to its ability to reduce the VIP-stimulated elevation in cAMP levels by 64%, the addition of 30 μM VIP(6-28) to culture medium does not significantly alter cAMP levels measured after stimulation of adult ganglia with either isoproterenol or forskolin (10 μM each). Similar results on the ability of VIP(6-28) to block VIP -stimulated increases in cAMP levels are obtained in neuron-enriched and in non-neuronal cell-en riched dissociated cultures.

target

VIP

VIP (6-28) (HUMAN, BOVINE, PORCINE, RAT)Supplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
Ascent Scientific
Tel
4401179829988
Email
customerservice@ascentscientific.co.uk
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696;
Email
info@hanhongsci.com